Loading...
Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE
OBJECTIVE: Glucocorticoids (GCs) are used as standard treatment for acute attacks of multiple sclerosis (MS). However, GCs eventually lose efficacy and do not prevent disease progression. Macrophage migration inhibitory factor (MIF) is the only known proinflammatory cytokine induced by GCs that inhi...
Saved in:
| Published in: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Lippincott Williams & Wilkins
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529283/ https://ncbi.nlm.nih.gov/pubmed/26280015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000139 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|